MSB 2.70% 95.0¢ mesoblast limited

Cell Therapy News/Articles, page-8290

  1. 15,520 Posts.
    lightbulb Created with Sketch. 5593
    Looks like therapeutics could be relied upon more than ever in the coming months ... bring on the 60 day data readouts me thinks .... surely there will be a place in the overall treatment regime for Remestemcel-L if these results show positive signs in various cohorts ?


    https://thehill.com/policy/healthca...us-variant-with-potentially-vaccine-resistant

    Study shows UK coronavirus variant with potentially vaccine-resistant mutation


    A variant of the coronavirus first found in the United Kingdom has gained a mutation that could make it more resistant to vaccines, according to a new analysis from Public Health England.

    The mutation, known as E484K, is linked to strains in Brazil and South Africa that have proved more resistant to existing vaccines.

    According to the analysis, estimated rates for cases with the mutation are 25 to 40 percent higher than estimated attack rates for other strains.

    The variant, known as B.1.1.7, was first discovered in December and spread rapidly across the U.K. It has since turned up in 72 countries. It is much more transmissible than other strains, and there is some evidence it could cause more deaths.

    In the U.S., the variant has been discovered in 32 states, though experts believe it is likely much more widespread and could become the dominant strain by March.
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
95.0¢
Change
0.025(2.70%)
Mkt cap ! $1.084B
Open High Low Value Volume
94.0¢ 96.8¢ 93.5¢ $4.207M 4.417M

Buyers (Bids)

No. Vol. Price($)
3 42268 94.0¢
 

Sellers (Offers)

Price($) Vol. No.
95.0¢ 48002 3
View Market Depth
Last trade - 16.10pm 09/08/2024 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.